NCT03440970View on ClinicalTrials.gov

Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

August 30, 2025

Study Completion Date

August 30, 2025

Conditions
Decompensated Heart Failure
Interventions
DRUG

Lysine Chloride

Patients will receive the study drug thrice daily for 5 days.

OTHER

Placebo

Patients will receive the placebo thrice daily for 5 days.

Trial Locations (1)

06510

Yale University, New Haven

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Yale University

OTHER

NCT03440970 - Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure | Biotech Hunter | Biotech Hunter